Antipsychotic meds decisions in assisted living require system-level perspective: study
By
Kimberly Bonvissuto
Jan 25, 2023
Decisions on administering as-needed antipsychotic drugs require balancing regulatory goals with resident-centered practices, researchers say.
Also in the news for Oct. 16, 2014 . . .
Oct 16, 2014
HIPAA authorization forms do not have be signed voluntarily to be valid, judge rules … Aluminum exposure ‘inevitably’ contributes to Alzheimer’s, researcher says … Judge holds...
Study: baby talk not suitable for adults with dementia
Jul 29, 2008
Sufferers of Alzheimer’s disease and other forms of dementia don’t like being talked down to any more than healthy, competent adults do, according to new research. So-called “elderspeak”...
Alzheimer’s drug discoveries and clinical development to be focal point of conference
Aug 30, 2013
The Alzheimer’s Drug Discovery Foundation will host its annual fall conference on Sept. 9-10 in Jersey City, NJ. The conference will bring together experts and scientists to present current drug...
Researchers identify five Alzheimer’s genes
Apr 05, 2011
Two new studies — which examined 50,000 subjects worldwide — have identified five new genes that are definitively associated with Alzheimer’s, according to a study published in the journal Nature...
McKnight’s to host webinar on brain fitness today
Nov 10, 2008
McKnight’s will offer a free Web seminar this afternoon on brain fitness. Registration for the event is still available at www.mcknights.com.
Sunrise ousts North American vice president in cost-saving move
Feb 04, 2010
Sunrise Senior Living Inc. on Monday said it will terminate the employment of Daniel Schwartz, senior vice president of North American Operations, effective May 31, 2010.
In a Senate hearing commemorating the 50th anniversary of the formation of the Special Committee on Aging, committee chairman, Sen. Herb Kohl (D-WI) said funding for home and community based services should...
Alzheimer’s drugs offer promise of treatment for other diseases
Jun 12, 2008
Drugs used to potentially treat Alzheimer’s disease may lead to advancements in the treatment of other afflictions, according to the Mayo Clinic.
Obama administration boosts Alzheimer’s research with $50 million in funding
Feb 08, 2012
The Obama administration has said it will devote $50 million to fund Alzheimer’s research this year, and an additional $80 million in 2013.